Free Trial
→ The latest trend in real estate (From Pacaso) (Ad)

20 Stocks Wall Street Analysts Love the Most - 14 of 20

Slide 14
Back to 13
Continue to 15
 
Back to 13
Continue to 15
 

Teva Pharmaceutical Industries (NYSE:TEVA)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
7 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$19.67 (18.7% Upside)

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries logoTeva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/23/2024BarclaysBoost Price TargetOverweight ➝ Overweight$22.00 ➝ $25.00
10/21/2024JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$16.00 ➝ $18.00
9/3/2024UBS GroupBoost Price TargetBuy ➝ Buy$24.00 ➝ $26.00
8/1/2024BarclaysBoost Price TargetOverweight ➝ Overweight$21.00 ➝ $22.00
7/10/2024UBS GroupBoost Price TargetBuy ➝ Buy$22.00 ➝ $24.00
7/10/2024ArgusUpgradeHold ➝ Buy$20.00
6/27/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$19.00 ➝ $23.00
6/5/2024BarclaysBoost Price TargetOverweight ➝ Overweight$20.00 ➝ $21.00
5/30/2024Bank of AmericaBoost Price TargetBuy ➝ Buy$18.00 ➝ $21.00
5/13/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$19.00 ➝ $20.00
Slide 14
Back to 13
Continue to 15
 

The latest trend in real estate (Ad)

These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.

Don’t miss your chance to maximize your stake in this co-ownership revolution.

More From MarketBeat
25X predicted for “Amazon Coin” – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
15 Stocks Institutional Investors Are Selling Now
Hedge funds, endowments, and other institutional investors have been selling shares of these 15 stocks in the ...
MarketBeat
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
7 Best Stocks to Own Right Now
Today, we invite you to view our list of the seven best stocks to own for the next thirty days. Why is it w...
MarketBeat
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
Betting on a Santa Claus Rally? Consider These 7 Risk-On Stocks
We're getting into the time of year when people start talking about a Santa Claus rally. Specifically, that's ...
MarketBeat